Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Jun 2024 01:57 PM
RNS
Person Closely Associated Dealing
24 Jun 2024 05:44 PM
RNS
Result of Annual General Meeting
21 Jun 2024 03:11 PM
RNS
Holding(s) in Company
20 Jun 2024 12:24 PM
RNS
Holding(s) in Company
20 Jun 2024 10:45 AM
RNS
Holding(s) in Company
20 Jun 2024 09:15 AM
RNS
Holding(s) in Company
19 Jun 2024 08:00 AM
RNS
Admission of Shares and Total Voting Rights
18 Jun 2024 07:00 AM
RNS
Subscription of shares by Institut Mérieux
03 Jun 2024 07:00 AM
RNS
Total Voting Rights
15 May 2024 03:52 PM
RNS
2024 Annual General Meeting Notification
01 May 2024 07:00 AM
RNS
Total Voting Rights
30 Apr 2024 05:00 PM
RNS
2023 Annual Report and Accounts
29 Apr 2024 09:38 AM
RNS
Prelim Results for Y/E 2023 - REPLACEMENT
29 Apr 2024 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2023
02 Apr 2024 07:00 AM
RNS
Total Voting Rights
20 Mar 2024 07:00 AM
RNS
Update on CDMO Services
11 Mar 2024 07:00 AM
RNS
Board Changes
05 Mar 2024 07:00 AM
RNS
Updated Financial Guidance and 2023 Trading
01 Mar 2024 07:00 AM
RNS
Total Voting Rights
15 Feb 2024 07:00 AM
RNS
Appointment of Joint Corporate Broker
01 Feb 2024 04:48 PM
RNS
Holding(s) in Company
01 Feb 2024 07:00 AM
RNS
Total Voting Rights
31 Jan 2024 07:00 AM
RNS
Block Listing Application
30 Jan 2024 07:00 AM
RNS
Total Voting Rights
29 Jan 2024 08:38 AM
RNS
Completion of Transaction
26 Jan 2024 03:09 PM
RNS
Block listing application
04 Jan 2024 11:49 AM
RNS
Director Declaration
02 Jan 2024 07:00 AM
RNS
Block Listing Return
02 Jan 2024 07:00 AM
RNS
Total Voting Rights
13 Dec 2023 07:00 AM
RNS
2023 AGM Post Meeting Update Statement
07 Dec 2023 07:00 AM
RNS
Business Update
04 Dec 2023 07:00 AM
RNS
Signing of agreement to acquire ABL Europe
01 Dec 2023 07:00 AM
RNS
Total Voting Rights
24 Nov 2023 07:00 AM
RNS
Grant of options
16 Nov 2023 03:32 PM
RNS
PDMR Dealing – Replacement
14 Nov 2023 01:43 PM
RNS
PDMR Dealings
01 Nov 2023 07:00 AM
RNS
Total Voting Rights
24 Oct 2023 06:17 PM
RNS
Holding(s) in Company
24 Oct 2023 05:36 PM
RNS
Holding(s) in Company
16 Oct 2023 07:00 AM
RNS
Holding(s) in Company
13 Oct 2023 07:00 AM
RNS
Holding(s) in Company
11 Oct 2023 11:33 AM
RNS
PDMR Dealings
04 Oct 2023 05:09 PM
RNS
Grant of Options
02 Oct 2023 03:06 PM
RNS
Total Voting Rights
27 Sep 2023 12:03 PM
RNS
PDMR / PCA Dealing
26 Sep 2023 03:47 PM
RNS
PDMR Dealings
22 Sep 2023 11:42 AM
RNS
PDMR Dealings
20 Sep 2023 11:42 AM
RNS
Director Dealings
20 Sep 2023 07:01 AM
RNS
Project Aquarius
20 Sep 2023 07:00 AM
RNS
Interim results

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings